Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| cbdMD, Inc.YCBD · Entity 8230 | Director | April 14, 2026 | April 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
cbdMD, Inc.
Report date April 14, 2026 · Filed April 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,412 |
Reported balance
After 2026-04-14 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-04-14 · Grant · Acquired 1,572 · Balance 4,412 F1: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted stock units vest quarterly on June 30, 2026, September 30, 2026, December 31, 2026 and March 31, 2027. The restricted stock units were issued under the 2021 or 2025 Equity Compensation Plan as compensation to the Reporting Person for services on the Issuer's Board of Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted stock units vest quarterly on June 30, 2026, September 30, 2026, December 31, 2026 and March 31, 2027. The restricted stock units were issued under the 2021 or 2025 Equity Compensation Plan as compensation to the Reporting Person for services on the Issuer's Board of Directors.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 14, 2026 Filed Apr 17, 2026 00:15 UTC | cbdMD, Inc. YCBD · Entity 8230 | GrantCommon Stock | 1,572 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-012587 · rdgdoc.xml · nonDerivative · entry 1 Stephen Scott G. · CIK 0001773957 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,412 F1 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted stock units vest quarterly on June 30, 2026, September 30, 2026, December 31, 2026 and March 31, 2027. The restricted stock units were issued under the 2021 or 2025 Equity Compensation Plan as compensation to the Reporting Person for services on the Issuer's Board of Directors. Read SEC document |
| May 16, 2025 Filed May 20, 2025 21:22 UTC | cbdMD, Inc. YCBD · Entity 8230 | GrantCommon Stock | 1,572 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-017866 · rdgdoc.xml · nonDerivative · entry 1 Stephen Scott G. · CIK 0001773957 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,840 F1 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted stock units vest quarterly on June 30, 2025, September 30, 2025, December 31, 2025 and March 31, 2026. The restricted stock units were issued under the 2021 Equity Compensation Plan as compensation to the Reporting Person for her services on the Issuer's Board of Directors. Read SEC document |
| March 29, 2024 Filed Apr 3, 2024 13:00 UTC | cbdMD, Inc. YCBD · Entity 8230 | GrantStock Options (Right to Buy) · Derivative | 2,000 | Not disclosed Strike: $0.93 | Not disclosed |
DisclosureSEC source: 0001437749-24-010750 · rdgdoc.xml · derivative · entry 2 Stephen Scott G. · CIK 0001773957 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2029-03-29 F2 · security: The stock options were granted under the 2021 Equity Compensation Plan as compensation to the Reporting Person for her services on the Issuer's Board of Directors for the Board term beginning March 29, 2024. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The stock options are fully vested. F3 · price: Not applicable. Read SEC document |
| March 29, 2024 Filed Apr 3, 2024 13:00 UTC | cbdMD, Inc. YCBD · Entity 8230 | GrantCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-010750 · rdgdoc.xml · nonDerivative · entry 1 Stephen Scott G. · CIK 0001773957 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,138 F1 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted stock units vest quarterly on June 30, 2024, September 30, 2024, December 31, 2024 and March 31, 2025. The restricted stock units were issued under the 2021 Equity Compensation Plan as compensation to the Reporting Person for her services on the Issuer's Board of Directors for the Board term beginning March 29, 2024. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 21:29 UTC | cbdMD, Inc. YCBD · Entity 8230 | GrantStock Options (Right to Buy) · Derivative | 30,000 | Not disclosed Strike: $0.28 | Not disclosed |
DisclosureSEC source: 0001437749-23-004159 · rdgdoc.xml · derivative · entry 2 Stephen Scott G. · CIK 0001773957 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2028-02-17 F2 · security: The stock options were granted under the 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning February 16, 2023. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The stock options are fully vested. F3 · price: Not applicable. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 21:29 UTC | cbdMD, Inc. YCBD · Entity 8230 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-004159 · rdgdoc.xml · nonDerivative · entry 1 Stephen Scott G. · CIK 0001773957 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,052 F1 · security: The restricted shares of common stock were issued under the 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning February 16, 2023. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted shares of common stock vest quarterly in equal increments on June 30, 2023, September 30, 2023, December 31, 2023 and March 31, 2024, subject to continued service as a director of the Issuer on each applicable vesting date. Read SEC document |
| March 11, 2022 Filed Apr 19, 2022 20:48 UTC | cbdMD, Inc. YCBD · Entity 8230 | GrantStock Options (Right to Buy) · Derivative | 30,000 | Not disclosed Strike: $0.82 | Not disclosed |
DisclosureSEC source: 0001654954-22-005149 · section16.xml · derivative · entry 2 Stephen Scott G. · CIK 0001773957 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2027-03-11 F2 · security: The stock options were granted under the 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning March 11, 2022. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of four non-employee directors. The stock options are fully vested. F3 · price: Not applicable. Read SEC document |
| March 11, 2022 Filed Apr 19, 2022 20:48 UTC | cbdMD, Inc. YCBD · Entity 8230 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-22-005149 · section16.xml · nonDerivative · entry 1 Stephen Scott G. · CIK 0001773957 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,052 F1 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of four non-employee directors. The restricted stock units vest quarterly in equal increments on June 30, 2022, September 30, 2022, December 31, 2022 and March 31, 2023, subject to continued service as a director of the Issuer on each applicable vesting date. Shares of common stock will be delivered to the Reporting Person upon the vesting of the restricted stock units. The restricted stock units were issued under the 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning March 11, 2022. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 13:55 UTC | cbdMD, Inc. YCBD · Entity 8230 | Grantstock option · Derivative | 30,000 | $0.00 Strike: $4.40 | $0.00 |
DisclosureSEC source: 0001654954-21-002852 · section16.xml · derivative · entry 5 Stephen Scott G. · CIK 0001773957 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: common stock · 30,000 shares Expires 2026-03-11 Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 13:55 UTC | cbdMD, Inc. YCBD · Entity 8230 | Grantrestricted stock award · Derivative | 1,250 | $4.40 Strike: $0.00 | $5,500.00 |
DisclosureSEC source: 0001654954-21-002852 · section16.xml · derivative · entry 4 Stephen Scott G. · CIK 0001773957 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250 Underlying: common stock · 1,250 shares Expires 2022-03-12 Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 13:55 UTC | cbdMD, Inc. YCBD · Entity 8230 | Grantrestricted stock award · Derivative | 1,250 | $4.40 Strike: $0.00 | $5,500.00 |
DisclosureSEC source: 0001654954-21-002852 · section16.xml · derivative · entry 3 Stephen Scott G. · CIK 0001773957 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250 Underlying: common stock · 1,250 shares Expires 2021-12-31 Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 13:55 UTC | cbdMD, Inc. YCBD · Entity 8230 | Grantrestricted stock award · Derivative | 1,250 | $4.40 Strike: $0.00 | $5,500.00 |
DisclosureSEC source: 0001654954-21-002852 · section16.xml · derivative · entry 2 Stephen Scott G. · CIK 0001773957 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250 Underlying: common stock · 1,250 shares Expires 2021-09-30 Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 13:55 UTC | cbdMD, Inc. YCBD · Entity 8230 | Grantrestricted stock award · Derivative | 1,250 | $4.40 Strike: $0.00 | $5,500.00 |
DisclosureSEC source: 0001654954-21-002852 · section16.xml · derivative · entry 1 Stephen Scott G. · CIK 0001773957 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250 Underlying: common stock · 1,250 shares Expires 2021-06-30 Read SEC document |
| March 12, 2021 Filed Oct 5, 2021 17:43 UTC Amendment | cbdMD, Inc. YCBD · Entity 8230 | GrantCommon stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-010810 · section16.xml · nonDerivative · entry 1 Stephen Scott G. · CIK 0001773957 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,052 F1 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted stock units vest quarterly in equal increments over a one year period from the grant date with the last vesting being on March 12, 2022, subject to continued service as a director of the Issuer on each applicable vesting date. Shares of common stock will be delivered to the Reporting Person upon the vesting of the restricted stock units. The restricted stock units were issued under the 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning March 12, 2021. Read SEC document |
| May 27, 2020 Filed May 28, 2020 20:47 UTC | cbdMD, Inc. YCBD · Entity 8230 | GrantStock Options · Derivative | 20,000 | $0.00 Strike: $1.57 | $0.00 |
DisclosureSEC source: 0001654954-20-006047 · section16.xml · derivative · entry 1 Stephen Scott G. · CIK 0001773957 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2030-05-27 Read SEC document |
| January 14, 2020 Filed Jan 16, 2020 12:03 UTC | cbdMD, Inc. YCBD · Entity 8230 | PurchaseCommon Stock | 20,000 | $1.00 | $20,000.00 |
DisclosureSEC source: 0001654954-20-000509 · section16.xml · nonDerivative · entry 1 Stephen Scott G. · CIK 0001773957 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,052 Read SEC document |
| May 09, 2019 Filed May 13, 2019 17:55 UTC | cbdMD, Inc. LEVB · Entity 8230 | GrantStock Option · Derivative | 20,000 | $0.00 Strike: $5.41 | $0.00 |
DisclosureSEC source: 0001654954-19-005752 · section16.xml · derivative · entry 1 Stephen Scott G. · CIK 0001773957 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · see footnote Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-05-09 F1 · ownership.nature: The number of shares acquired represents shares underlying options issued to Ventana Vista LLC ("Ventana") of which Mr. Scott Stephen holds voting and dispositive control over securities held of record by Ventana. Mr. Stephen disclaims beneficial ownership of the securities held of record by Ventana except to the extent of his pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.